Northwestern inks $65M investment partnership to support research

Northwestern University announced an investment partnership with Deerfield Management. (Eugene_Moerman)

Northwestern University announced a deal to create a $65 million venture play with New York City-based Deerfield Management to support drug development at the university.

Lakeside Discovery will target funding and development expertise to advance "novel biomedical discoveries" at the university and strengthen its reputation as an academic medical research center, officials said in a release.

Lakeside will take on projects approved by a joint steering committee comprised of members from Northwestern's and Deerfield's scientific leadership teams which have a complete development plan, including experiments needed to reach investigational new drug status.   


9 Tips for Implementing the Best Mobile App Strategy

The member mobile app is a powerful tool for payers and members. It can help improve health outcomes, reduce operational costs, and drive self-service — anytime, anywhere. In this new eBook, learn tips and tricks to implementing the best mobile app strategy now.

“Lakeside will highlight Chicago as a preeminent hub for tomorrow’s cures, with the best medical researchers and clinicians working to improve the lives of patients,” said Alicia Löffler, executive director of Northwestern’s Innovation and New Ventures Office (INVO), in a statement.

RELATED: Health technology startups and innovators: Ignore physicians at your product’s peril

The creation of the fund comes as the university plans to open its new Louis A. Simpson and Kimberly K. Querrey Biomedical Research Center in 2019.

The university also has a number of investment partnerships including Baxter International and AbbVie, but none of this size, the Chicago Tribune reported. Deerfield has a similar arrangement with other universities, including Johns Hopkins University.

RELATED: Johns Hopkins, Northwestern lead $25M initiative to create a health informatics collaborative

Deerfield officials said the group is investing in Northwestern, in part, because of its track record in translational research in drug development. Researchers at Northwestern discovered fibromyalgia drug Lyrica, marketed by Pfizer.

“Additionally, supporting life-science discovery with INVO as a resource can help enhance the ecosystem at large in Chicago,” said James Flynn, Deerfield’s managing partner.

Suggested Articles

CMS expects Medicare Advantage and Part D payments to rise by 2.82% in 2022 after taking into account several regulatory changes.

Novartis announced it will restrict 340B sales to contract pharmacies, but only to those pharmacies more than 40 miles away from the 340B hospital.

While the rush to telehealth adoption may have slowed a bit from its highs early on in the pandemic, the data show consumer interest in virtual care.